Compounds > pyrazines
Page last updated: 2024-08-21

pyrazines and sildenafil citrate

pyrazines has been researched along with sildenafil citrate in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Anzaldi, M; Galietta, LJ; Mazzei, M; Mazzei, MT; Nieddu, E; Pedemonte, N; Pesce, E; Pollarolo, B; Schenone, S1
Boerema-de Munck, A; Burgisser, PE; Buscop-van Kempen, MJ; Dzyubachyk, O; Kool, HM; Mous, DS; Nagata, K; Rottier, RJ; Tibboel, D; van Rosmalen, J; Wijnen, RMH1
Akerström, F; Berenguel Senén, A; Escribano Subías, P; Lázaro Salvador, M; Martinez Mateo, V; Rodriguez Padial, L1
Bialesova, L; Bouchard, A; Kinsella, BT; Mulvaney, EP; Reid, HM; Salvail, D1
Amin, EK; Austin, ED; Colglazier, E; Fineman, JR; Hemnes, AR; Leary, PJ; Nawaytou, H; Parker, C; Teitel, D1

Other Studies

5 other study(ies) available for pyrazines and sildenafil citrate

ArticleYear
The search for a common structural moiety among selected pharmacological correctors of the mutant CFTR chloride channel.
    Future medicinal chemistry, 2014, Volume: 6, Issue:17

    Topics: Anisoles; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Gene Deletion; Humans; Models, Molecular; Molecular Conformation; Piperazines; Purines; Pyrazines; Sildenafil Citrate; Sulfonamides; Thiazoles; Vasodilator Agents

2014
Treatment of rat congenital diaphragmatic hernia with sildenafil and NS-304, selexipag's active compound, at the pseudoglandular stage improves lung vasculature.
    American journal of physiology. Lung cellular and molecular physiology, 2018, 08-01, Volume: 315, Issue:2

    Topics: Acetamides; Animals; Drug Therapy, Combination; Hernias, Diaphragmatic, Congenital; Humans; Lung; Pyrazines; Rats; Rats, Sprague-Dawley; Sildenafil Citrate

2018
Living With Severe Pulmonary Arterial Hypertension Without an Infusion Pump? Selexipag has a Role to Play.
    Archivos de bronconeumologia, 2019, Volume: 55, Issue:2

    Topics: Acetamides; Antihypertensive Agents; Drug Substitution; Drug Therapy, Combination; Epoprostenol; Female; Humans; Infusion Pumps; Middle Aged; Phenylpropionates; Pulmonary Arterial Hypertension; Pyrazines; Pyridazines; Sildenafil Citrate; Tadalafil; Vasodilator Agents

2019
NTP42, a novel antagonist of the thromboxane receptor, attenuates experimentally induced pulmonary arterial hypertension.
    BMC pulmonary medicine, 2020, Apr-06, Volume: 20, Issue:1

    Topics: Acetamides; Animals; Antihypertensive Agents; Disease Models, Animal; Heart Ventricles; Hemodynamics; Humans; Hypertrophy, Right Ventricular; Male; Monocrotaline; Pulmonary Arterial Hypertension; Pulmonary Artery; Pyrazines; Rats; Rats, Inbred WKY; Receptors, Thromboxane; Sildenafil Citrate; Vascular Remodeling

2020
Novel Documentation of Onset and Rapid Advancement of Pulmonary Arterial Hypertension without Symptoms in BMPR2 Mutation Carriers: Cautionary Tales?
    American journal of respiratory and critical care medicine, 2020, 12-01, Volume: 202, Issue:11

    Topics: Acetamides; Adolescent; Antihypertensive Agents; Asymptomatic Diseases; Bone Morphogenetic Protein Receptors, Type II; Cardiac Catheterization; Disease Progression; Dyspnea; Echocardiography; Exercise Tolerance; Female; Genetic Testing; Heterozygote; Humans; Male; Phenylpropionates; Pulmonary Arterial Hypertension; Pyrazines; Pyridazines; Sildenafil Citrate; Syncope; Vasodilator Agents

2020